This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Zhejiang Huahai Pharmaceutical Co., Ltd.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Xiaoren Zhu - Innovator in Pharmaceutical Synthesis
Introduction
Xiaoren Zhu is a prominent inventor based in Taizhou, China, known for his contributions to the pharmaceutical industry. With a focus on innovative synthesis methods, he has successfully developed techniques that enhance the production of vital medications. His work reflects a commitment to advancing healthcare through scientific innovation.
Latest Patents
Xiaoren Zhu holds a patent for a method of synthesizing valsartan, a crucial medication used to treat high blood pressure and heart failure. The patented method involves several detailed steps: synthesizing a valsartan methyl ester intermediate, diluting it with salt water or water, and using a specific extraction solvent for further purification. The process includes hydrolyzing the intermediate with alkali, regulating pH levels, and ultimately crystallizing and drying the product to obtain pure valsartan.
Career Highlights
Xiaoren Zhu is associated with Zhejiang Huahai Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical synthesis. His dedication to improving drug manufacturing processes has positioned him as a key player in the industry. His innovative approaches not only streamline production but also contribute to the availability of essential medications for patients worldwide.
Collaborations
Throughout his career, Xiaoren has collaborated with talented professionals, including Xiaohui Zhou and Yuanxun Zhu. These collaborations foster an environment of innovation and mutual learning, helping to push the boundaries of pharmaceutical research and development.
Conclusion
Xiaoren Zhu stands out in the field of pharmaceutical inventions with his unique approach to synthesizing critical medications like valsartan. His work at Zhejiang Huahai Pharmaceutical Co., Ltd. and collaborations with fellow researchers continue to contribute to advancements in the pharmaceutical industry, ultimately benefiting patients globally.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile